Dry Eye

Azura has secured funding to support its 2-stage study evaluating the safety, tolerability, and efficacy of AZR-MD-001, its leading candidate, for patients with contact lens discomfort who show signs of meibomian gland dysfunction.

Bausch + Lomb and Novaliqu announced that the FDA has accepted its New Drug Application for NOV03, an investigational treatment for dry eye disease associated with meibomian gland dysfunction.

FDA-approved steroid offers short-term relief for ocular surface inflammation.

Ensure successful symptoms management with your patients.

Latest transaction, totaling approximately $770 million, adds key commercial products and clinical/preclinical product candidates in the pipeline.

Optometry Times' editor Kassi Jackson speaks with Lauretta Justin, OD, founder of Optometry Divas, and Lisa Hornick, OD, recipient of Optometry Divas' Thought Leader of the Year 2022 award.

COMET-3 is the second of 3 studies in the AR-15512 Registrational Phase 3 Program, which is slated for completion by 2023.

One OD shares his experience launching a successful social media campaign for Dry Eye Awareness month—and offers 3 tips for crafting a message to capture an audience's attention.

Contact lenses soaked in melatonin analogs may be able to address aqueous tear deficient dry eye disease, researchers say.

Lindsay A. Sicks, OD, FAAO, shares her number 1 tip for managing dry eye.

Case gives new perspective on subconjunctival hemorrhages

The first-of-its-kind alliance and latest phase of AOA's national public awareness campaign focuses on the effects of extended time on digital devices and its impact on eye health.

Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, shares his number 1 tip for managing dry eye.

Best practices to help patients enjoy their trip to the fullest.

Alissa M. Coyne, OD, FAAO, FASOS, gives her number 1 tip for managing dry eye.

Drug submission of the first water-free therapy took place at the end of June, according to the companies.

The company intends to develop the AcuStream technology for potential use with its current and future front-of-eye therapies, which may include lifitegrast ophthalmic solution for the treatment of dry eye disease.

A plethora of treatments are available when patients, particularly contact lens wearers, are assessed at disease onset.

See this week's cartoon!

The COMET-2 study is the first of three studies in the AR-15512 phase 3 registration program, with topline results expected by the second half of 2023.

This far-less-understood option can fill multiple needs for a practice.

Practices must efficiently integrate optometry and ophthalmology, delegating appropriate care to the proper specialist, in order to ensure patients’ total eye care needs are best met.

Maria Sampalis, OD, shares the common habits her dry eye patients have that lead them to developing the disease.

Canine patient case study reveals a surprising diagnosis

New book offers guidelines for understanding and eliminating symptoms of eyestrain.